A Review of the Pharmacological Properties of Psoralen
Psoralen is the principal bioactive component in the dried fruits of Cullen corylifolium (L.) Medik (syn. Psoralea corylifolia L), termed “Buguzhi” in traditional Chinese medicine (TCM). Recent studies have demonstrated that psoralen displays multiple bioactive properties, beneficial for the treatme...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.571535/full |
id |
doaj-18082cadcf6a4a18a9fbefedf91e897b |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yali Ren Xiaominting Song Lu Tan Chuanjie Guo Miao Wang Hui Liu Zhixing Cao Yuzhi Li Cheng Peng |
spellingShingle |
Yali Ren Xiaominting Song Lu Tan Chuanjie Guo Miao Wang Hui Liu Zhixing Cao Yuzhi Li Cheng Peng A Review of the Pharmacological Properties of Psoralen Frontiers in Pharmacology psoralen osteoporosis tumor inflammatory Severe Acute Respiratory Syndrome Coronavirus 2 |
author_facet |
Yali Ren Xiaominting Song Lu Tan Chuanjie Guo Miao Wang Hui Liu Zhixing Cao Yuzhi Li Cheng Peng |
author_sort |
Yali Ren |
title |
A Review of the Pharmacological Properties of Psoralen |
title_short |
A Review of the Pharmacological Properties of Psoralen |
title_full |
A Review of the Pharmacological Properties of Psoralen |
title_fullStr |
A Review of the Pharmacological Properties of Psoralen |
title_full_unstemmed |
A Review of the Pharmacological Properties of Psoralen |
title_sort |
review of the pharmacological properties of psoralen |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2020-09-01 |
description |
Psoralen is the principal bioactive component in the dried fruits of Cullen corylifolium (L.) Medik (syn. Psoralea corylifolia L), termed “Buguzhi” in traditional Chinese medicine (TCM). Recent studies have demonstrated that psoralen displays multiple bioactive properties, beneficial for the treatment of osteoporosis, tumors, viruses, bacteria, and inflammation. The present review focuses on the research evidence relating to the properties of psoralen gathered over recent years. Firstly, multiple studies have demonstrated that psoralen exerts strong anti-osteoporotic effects via regulation of osteoblast/osteoclast/chondrocyte differentiation or activation due to the participation in multiple molecular mechanisms of the wnt/β-catenin, bone morphogenetic protein (BMP), inositol-requiring enzyme 1 (IRE1)/apoptosis signaling kinase 1 (ASK1)/c-jun N-terminal kinase (JNK) and the Protein Kinase B(AKT)/activator protein-1 (AP-1) axis, and the expression of miR-488, peroxisome proliferators-activated receptor-gamma (PPARγ), and matrix metalloproteinases (MMPs). In addition, the antitumor properties of psoralen are associated with the induction of ER stress-related cell death via enhancement of PERK: Pancreatic Endoplasmic Reticulum Kinase (PERK)/activating transcription factor (ATF), 78kD glucose-regulated protein (GRP78)/C/EBP homologous protein (CHOP), and 94kD glucose-regulated protein (GRP94)/CHOP signaling, and inhibition of P-glycoprotein (P-gp) or ATPase that overcomes multidrug resistance. Furthermore, multiple articles have shown that the antibacterial, anti-inflammatory and neuroprotective effects of psoralen are a result of its interaction with viral polymerase (Pol), destroying the formation of biofilm, and regulating the activation of tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β), interleukin 4/5/6/8/12/13 (IL-4/5/6/8/12/13), GATA-3, acetylcholinesterase (AChE), and the hypothalamic-pituitary-adrenal (HPA) axis. Finally, the toxic effects and mechanisms of action of psoralen have also been reviewed. |
topic |
psoralen osteoporosis tumor inflammatory Severe Acute Respiratory Syndrome Coronavirus 2 |
url |
https://www.frontiersin.org/article/10.3389/fphar.2020.571535/full |
work_keys_str_mv |
AT yaliren areviewofthepharmacologicalpropertiesofpsoralen AT xiaomintingsong areviewofthepharmacologicalpropertiesofpsoralen AT lutan areviewofthepharmacologicalpropertiesofpsoralen AT chuanjieguo areviewofthepharmacologicalpropertiesofpsoralen AT miaowang areviewofthepharmacologicalpropertiesofpsoralen AT huiliu areviewofthepharmacologicalpropertiesofpsoralen AT zhixingcao areviewofthepharmacologicalpropertiesofpsoralen AT yuzhili areviewofthepharmacologicalpropertiesofpsoralen AT chengpeng areviewofthepharmacologicalpropertiesofpsoralen AT yaliren reviewofthepharmacologicalpropertiesofpsoralen AT xiaomintingsong reviewofthepharmacologicalpropertiesofpsoralen AT lutan reviewofthepharmacologicalpropertiesofpsoralen AT chuanjieguo reviewofthepharmacologicalpropertiesofpsoralen AT miaowang reviewofthepharmacologicalpropertiesofpsoralen AT huiliu reviewofthepharmacologicalpropertiesofpsoralen AT zhixingcao reviewofthepharmacologicalpropertiesofpsoralen AT yuzhili reviewofthepharmacologicalpropertiesofpsoralen AT chengpeng reviewofthepharmacologicalpropertiesofpsoralen |
_version_ |
1724597750048227328 |
spelling |
doaj-18082cadcf6a4a18a9fbefedf91e897b2020-11-25T03:25:18ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-09-011110.3389/fphar.2020.571535571535A Review of the Pharmacological Properties of PsoralenYali Ren0Xiaominting Song1Lu Tan2Chuanjie Guo3Miao Wang4Hui Liu5Zhixing Cao6Yuzhi Li7Cheng Peng8School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaJiangsu Key Laboratory of Drug Discovery for Metabolic Disease, China, Pharmaceutical University, Nanjing, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Key Laboratory of Standardization for Chinese Herbal Medicine, Ministry of Education, National Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources, Chengdu, ChinaPsoralen is the principal bioactive component in the dried fruits of Cullen corylifolium (L.) Medik (syn. Psoralea corylifolia L), termed “Buguzhi” in traditional Chinese medicine (TCM). Recent studies have demonstrated that psoralen displays multiple bioactive properties, beneficial for the treatment of osteoporosis, tumors, viruses, bacteria, and inflammation. The present review focuses on the research evidence relating to the properties of psoralen gathered over recent years. Firstly, multiple studies have demonstrated that psoralen exerts strong anti-osteoporotic effects via regulation of osteoblast/osteoclast/chondrocyte differentiation or activation due to the participation in multiple molecular mechanisms of the wnt/β-catenin, bone morphogenetic protein (BMP), inositol-requiring enzyme 1 (IRE1)/apoptosis signaling kinase 1 (ASK1)/c-jun N-terminal kinase (JNK) and the Protein Kinase B(AKT)/activator protein-1 (AP-1) axis, and the expression of miR-488, peroxisome proliferators-activated receptor-gamma (PPARγ), and matrix metalloproteinases (MMPs). In addition, the antitumor properties of psoralen are associated with the induction of ER stress-related cell death via enhancement of PERK: Pancreatic Endoplasmic Reticulum Kinase (PERK)/activating transcription factor (ATF), 78kD glucose-regulated protein (GRP78)/C/EBP homologous protein (CHOP), and 94kD glucose-regulated protein (GRP94)/CHOP signaling, and inhibition of P-glycoprotein (P-gp) or ATPase that overcomes multidrug resistance. Furthermore, multiple articles have shown that the antibacterial, anti-inflammatory and neuroprotective effects of psoralen are a result of its interaction with viral polymerase (Pol), destroying the formation of biofilm, and regulating the activation of tumor necrosis factor alpha (TNF-α), transforming growth factor beta (TGF-β), interleukin 4/5/6/8/12/13 (IL-4/5/6/8/12/13), GATA-3, acetylcholinesterase (AChE), and the hypothalamic-pituitary-adrenal (HPA) axis. Finally, the toxic effects and mechanisms of action of psoralen have also been reviewed.https://www.frontiersin.org/article/10.3389/fphar.2020.571535/fullpsoralenosteoporosistumorinflammatorySevere Acute Respiratory Syndrome Coronavirus 2 |